Phase II study of sorafenib and pemetrexed after 1st line platinum chemotherapy in advanced stage IIIB malignant effusion or IV non small cell lung cancer
Latest Information Update: 04 Jan 2007
At a glance
- Drugs Pemetrexed (Primary) ; Sorafenib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 04 Jan 2007 New trial record.